Humanigen Inc (fka HGENQ)

[PITrader87]

Three conferences next week....

Humanigen to Present at Multiple Upcoming Investor Conferences
1:30 pm ET January 5, 2021 (BusinessWire) Print
Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called 'cytokine storm' with its lead drug candidate, lenzilumab(TM), today announced that the Company's management team will present and host meetings with investors and potential partners next week at the H.C. Wainwright BioConnect Conference, J.P. Morgan Healthcare Conference and 23rd Annual ICR Conference being held virtually between January 11-14, 2021.

Management will provide an update on enrollment for its Phase 3 clinical trial of lenzilumab in patients hospitalized with COVID-19, an update on the commercial preparation ahead of a potential Emergency Use Authorization (EUA) for lenzilumab as well as an overview of the Company's other programs.

Details for the upcoming virtual investor conferences are below:

H.C. Wainwright BioConnect Conference

Date: Monday, January 11, 2021 Presentation Viewable Starting at 6:00 AM ET Event Link: https://journey.ct.events/view/b7204c9c-e187-4cbf-abf0-cb4bd62e817c

J.P. Morgan Healthcare Conference

Date: Wednesday, January 13, 2021 Presentation Time: 8:20 AM ET Event Link: https://jpmorgan.metameetings.net/events/healthcare21/sessions/35565-humanigen/webcast?gpu_only=true&kiosk=true

2021 ICR Conference

Date: Thursday, January 14, 2021 Fireside Chat with Cosme Ordonez, National Securities: 1:00 PM ET Event Link: https://icrinc.touchcast.com/showtime/icr-conference/embed/19b8209f-86ae-93a7-6351-107304d2f9d0